City of St. Louis: 9 companies received FDA inspections in Q1
There were nine companies in the City of St. Louis that received nine FDA inspections in the first quarter of 2026, according to the U.S. Food and Drug Administration.
More News
Which ex-high school standouts featured in St. Louis city will compete on Friday, April 3?
Friday, April 3 will see these former St. Louis city area high school stars in competition.
American Legislative Exchange Council argues 340B program raises costs and misses underserved communities, as scrutiny builds in Missouri
The American Legislative Exchange Council (ALEC) said the federal 340B Drug Pricing Program may be driving up costs for taxpayers and patients while falling short of helping the underserved communities it was meant to support.
Public Policy VP Mihalick scrutinizes 340B program for ‘shortchanging patients to increase profits,’ as 340B concerns grow in Missouri
Peter Mihalick of the American Medical Informatics Association warned that the 340B Drug Pricing Program may incentivize nonprofit hospitals to prioritize profits over patient savings, as scrutiny over the program continues to grow.
Rep. Marshall raises concerns about 340B expansion as scrutiny grows over Missouri’s use of the drug program
Rep. Matt Marshall said any expansion of the 340B Drug Pricing Program should include stronger transparency and accountability measures to ensure it benefits the patients it was designed to serve.
Who are the former St. Louis city high school standouts competing in the week of Monday, March 16?
The week beginning Monday, March 16 will showcase these former St. Louis city area high school standouts.
UCSF professor flags $1.34B Minnesota 340B windfall, as scrutiny grows over Missouri’s use of the program
A new Minnesota 340B report suggests the program is generating billion-dollar revenue for hospitals and driving consolidation rather than supporting safety-net care, according to UCSF assistant professor Anthony DiGiorgio.
BlackDoctor.org calls for reforms to federal 340B drug pricing program impacting Missouri
A health and wellness website is calling for increased scrutiny of the 340B Drug Pricing Program, urging patient-centered reforms focused on transparency and accountability.
Hearing announced on prescription drug costs in Congress
Congressmen Brett Guthrie and Morgan Griffith are set to hold a second hearing examining prescription drug costs as part of efforts to improve healthcare affordability.